Literature DB >> 12505582

Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.

Sana M Al-Khatib1, Nancy M Allen LaPointe, Lesley H Curtis, Judith M Kramer, Joslyn Swann, Peter Honig, Robert M Califf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12505582     DOI： 10.1016/s0002-9149(02)03008-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Authors:  Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2010-07-10       Impact factor: 5.460

2.  Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.

Authors:  Nancy M Allen LaPointe; Dadi Dai; Laine Thomas; Jonathan P Piccini; Eric D Peterson; Sana M Al-Khatib
Journal:  Am J Cardiol       Date:  2014-11-13       Impact factor: 2.778

Review 3.  Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.

Authors:  Etienne Aliot; Alessandro Capucci; Harry J Crijns; Andreas Goette; Juan Tamargo
Journal:  Europace       Date:  2010-12-07       Impact factor: 5.214

4.  Amiodarone-Induced Liver Injury and Cirrhosis.

Authors:  Jonathan Buggey; Matthew Kappus; Anand S Lagoo; Carla W Brady
Journal:  ACG Case Rep J       Date:  2015-01-16

Review 5.  Amiodarone in the aged.

Authors:  Meera Srinivasan; Laura Ahmad; Ravinay Bhindi; Usaid Allahwala
Journal:  Aust Prescr       Date:  2019-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.